Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ADMA Biologics Inc - Common Stock
(NQ:
ADMA
)
19.25
-0.13 (-0.67%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ADMA Biologics Inc - Common Stock
< Previous
1
2
3
Next >
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
November 05, 2025
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
October 29, 2025
Conference Call Scheduled for November 5, 2025, at 4:30 p.m. ET
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
August 06, 2025
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
July 30, 2025
Conference Call Scheduled for August 6, 2025, at 4:30 p.m. ET
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
May 07, 2025
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
April 30, 2025
Conference Call Scheduled for May 7, 2025, at 4:30 p.m. ET
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
April 29, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:POAI),(NASDAQ:ADMA) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
April 28, 2025
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
April 29, 2025
From
FN Media Group LLC
Via
GlobeNewswire
ADMA Biologics Statement on Tariffs
April 07, 2025
Reiterates Strategic Advantage Through Fully U.S.-Based Manufacturing Operations, Commercialization and End-Market Sales, and Vertically Integrated U.S.-Based Supply Chain
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 03, 2025
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
February 28, 2025
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
February 25, 2025
Conference Call Scheduled for March 3, 2025, at 4:30 p.m. ET
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update
January 13, 2025
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025
January 07, 2025
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
December 20, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm
December 13, 2024
Via
ACCESSWIRE
The Schall Law Firm Invites Shareholder Participation In An Inquiry Into ADMA Biologics Inc For Securities Law Violations
December 12, 2024
Via
ACCESSWIRE
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm
November 12, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kirby McInerney LLP Reminds ADMA Biologics, Inc. (ADMA) Investors of Shareholder Investigation
November 09, 2024
From
Kirby McInerney LLP
Via
Business Wire
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
November 07, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against ADMA Biologics, Inc. (ADMA)
November 05, 2024
From
Kirby McInerney LLP
Via
Business Wire
ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm
November 05, 2024
From
The Schall Law Firm
Via
Business Wire
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
October 29, 2024
Conference Call Scheduled for November 7, 2024, at 4:30 p.m. ET
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm
October 29, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm
October 28, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Bragar Eagel & Squire, P.C. Is Investigating ADMA Biologics, Napco, and L&W and Encourages Investors to Contact the Firm
October 21, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm
October 15, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ADMA Biologics Set to Join S&P SmallCap 600 Index
September 17, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
September 10, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
